$22 out-of-pocket costs
for many eligible patients;
The NAFTIN® (Naftifine HCl) Gel, 2% co‑pay savings program3
Help patients save on prescriptions
View Savings Card
- $22 out-of-pocket costs for many eligible patients; restrictions apply
- Offer not valid for patients covered by Medicare, Medicaid, or any federal or state pharmaceutical assistance programs
ELIGIBILITY CRITERIA & TERMS:
This savings card is not valid for use by patients (a) Aged 11 years or younger or (b) covered by
any federal or state funded healthcare program (including, but not limited to, Medicare (Part D and
Medigap), Medicaid, any state pharmaceutical assistance program, TRICARE, VA, or DoD), or private
indemnity or HMO insurance plans that reimburse patient for the entire cost of prescription drugs.
Offer good only in the U.S., including Puerto Rico. Not valid if an AB-rated generic drug is
available for the product.
Void where prohibited by law, taxed, or restricted. This offer cannot be
combined with any other promotional offer. Sebela Pharmaceuticals reserves the right to rescind, revoke, or amend
this offer without notice at any time. No cash value. Not eligible for sale, purchase, trade or
ExpandCollapseClick to See Complete Safety InformationClose
NAFTIN® (Naftifine HCl) Gel, 2%
INDICATIONS AND USAGE
NAFTIN GEL, 2% is an allylamine antifungal indicated for the treatment of interdigital tinea pedis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum in patients 12 years of age and older.
IMPORTANT SAFETY INFORMATION ADVERSE REACTIONS
In clinical trials with NAFTIN Gel, 2%, the most common adverse reactions (2%) were application site reactions.
WARNINGS AND PRECAUTIONS
If redness or irritation develops with the use of NAFTIN Gel, 2%, treatment should be discontinued.